Dog's Vision Restored
A 9-year-old bluetick beagle named Ziggy, who lost vision in one eye due to a rare autoimmune disease, has had his eyesight preserved with a unique treatment involving a steroid injection, and his vision was restored within a week to 10 days
A veterinarian at the Virginia-Maryland College of Veterinary Medicine's Veterinary Teaching Hospital has applied a unique treatment to preserve the eyesight of a 9-year-old bluetick beagle named Ziggy. Ziggy was suffering from a rare autoimmune disease called uveodermatologic syndrome, which had already caused him to lose vision in one eye due to severe glaucoma.
The standard treatment for uveodermatologic syndrome involves immunosuppressive drugs, but in Ziggy's case, this could have put his spine at risk due to inflammation. Instead, Ian Herring, associate professor of ophthalmology, treated Ziggy with a steroid injection adjacent to his eye as part of a novel approach to manage his condition.
Within a week to 10 days after the injection, Ziggy's vision was restored. Ziggy's case began just before Thanksgiving 2025, when his third eyelid was protruding and he was squinting. X-rays revealed lesions along Ziggy's mid-back, signs of discospondylitis.
Ziggy's owner, Aparna Shah, a collegiate assistant professor of neuroscience at Virginia Tech, noticed that Ziggy had started walking toward the wrong doors in their home, indicating that he was having trouble with his vision. Shah and her husband brought Ziggy to the Veterinary Teaching Hospital, where Herring and his team found a partially detached retina.
Herring plans to use Ziggy's case to inform future treatments for the condition. The success of the novel approach in preserving Ziggy's eyesight is a significant development in the treatment of uveodermatologic syndrome, and it may help other dogs suffering from the same condition.
## What happens next Ziggy's case will shape how Herring treats the condition from now on. The unique treatment used to preserve Ziggy's eyesight may become a new standard for treating uveodermatologic syndrome, especially in cases where immunosuppressive drugs are not a viable option.
## Why it matters The preservation of Ziggy's eyesight is not only a significant development in the treatment of uveodermatologic syndrome but also a testament to the importance of innovative approaches in veterinary medicine. The success of the novel treatment used in Ziggy's case may lead to new treatments and improved outcomes for dogs suffering from similar conditions.
